Sign in
4

Changes in Ownership

Phreesia, Inc. Filed Acc 0001127602-24-029339

SVP, Life Sciences sold 11,853 shares at $24.85 ($294,559)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Linetsky David · SVP, Life Sciences

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-11 Sale : show line 1 in the form 10b5-1 −11,853 $24.85 $294,559 188,354 D
Open-market sales · 11,853 sh · avg $24.85 · $294,559
Loading xslF345X05/form4.xml…